# Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder

> **NCT01473394** · PHASE4 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 518 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Dose-matched placebo
- **DRUG:** Vilazodone

## Key facts

- **NCT ID:** NCT01473394
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 518 (ACTUAL)
- **Last updated:** 2014-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01473394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01473394, "Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT01473394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*